We use cookies to measure traffic and show relevant ads. By clicking Accept you agree to our use of analytics and advertising cookies.
了解 dubodencel 如何从 FDA 获得第三个快速通道资格,用于治疗胶质母细胞瘤、胰腺癌和黑色素瘤。分析双负载树突状细胞平台及患者前景。
FDA授予dubodencel(DOC1021)疗法快速通道资格,用于治疗不可切除的黑色素瘤。了解个性化树突状细胞疫苗如何改变肿瘤免疫学。